Bicara Therapeutics

Bicara Therapeutics is a biotechnology company focused on developing innovative cancer therapies. They specialize in creating bifunctional antibodies that target both the immune system and the tumor microenvironment to enhance anti-tumor activity. The company generates revenue through partnerships, licensing agreements, and the development of proprietary therapies. Founded in 2019, Bicara has rapidly advanced its pipeline, leveraging cutting-edge science and strategic collaborations to address unmet medical needs in oncology.

Recent Posts by Bicara Therapeutics

1-7 of 7